Please Wait

Applying Filters...

Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Piperacillin Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

44 API Suppliers, 14 USDMF, 15 CEP/COS, 13 JDMF, 1 EU WC, 10 KDMF, 13 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

FINISHED DOSAGE FORMULATIONS

294 FDF Dossiers, 70 FDA Orange Book, 154 Europe, 16 Canada, 15 South Africa, 39 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML, INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML, INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 Kirsch Pharma, 3 Dr. Paul Lohmann GmbH & Co. KGaA, 1 Actylis, 4 Roquette

EXCIPIENTS BY APPLICATIONS

6 Parenteral, 4 API Stability Enhancers, 2 Fillers, Diluents & Binders, 1 Topical, 1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 33 News #PharmaBuzz

GLOBAL SALES INFORMATION

24 US Medicaid Prescriptions, 38 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

7 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 11 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
27/02/2026	Fresenius Kabi AB Brunna	Sweden	Sangjin Trading Co., Ltd.	20190829-95-E-153-07	piperacillin hydrate	2019-08-29	Fresenius Kabi IPSUM SRL	Italy	Via San Leonardo, 23 – 45010 VILLADOSE (RO), Italy
27/02/2026	Fresenius Kabi AB Brunna	Sweden	Chong Kun Dang Co., Ltd.	20120814-95-E-98-02(3)	piperacillin sodium	2017-09-01	Fresenius Kabi iPSUM Srl	Italy	Via A. Boito, 13 I-20053 Taccona Di Muggio (MB) (Synthetic manufacturer: Via S. Leonardo, 23 1-45010 Villadose (RO), Italy)

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Piperacillin Sodium

Piperacillin Sodium

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

44 API Suppliers

14 USDMF

15 CEP/COS

13 JDMF

1 EU WC

10 KDMF

13 NDC API

8 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

8 Drugs in Development

FINISHED DOSAGE FORMULATIONS

294 FDF Dossiers

70 FDA Orange Book

154 Europe

16 Canada

15 South Africa

39 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML

INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML

INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

3 Kirsch Pharma

3 Dr. Paul Lohmann GmbH & Co. KGaA

1 Actylis

4 Roquette

EXCIPIENTS BY APPLICATIONS

6 Parenteral

4 API Stability Enhancers

2 Fillers, Diluents & Binders

1 Topical

1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

33 News #PharmaBuzz

GLOBAL SALES INFORMATION

24 US Medicaid Prescriptions

38 Regulatory FDF Prices

7 Annual Reports

MARKET PLACE

7 APIs

5 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM

4 USP

11 Others

Filters

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons